Literature DB >> 15194074

Reliability of identification of 655 sentinel lymph nodes in 263 consecutive patients with malignant melanoma.

Stephan Ariyan1, Charlotte Ariyan, Leonard R Farber, David S Fischer, Stuart D Flynn, Carolyn Truini.   

Abstract

BACKGROUND: The purpose of this study of sentinel lymph node biopsies (SLN) was threefold: to compare the reliability of lymphazurin blue dye to radioactive technetium 99m sulfur colloid (TC); to evaluate the reliability of frozen section examinations of sentinel lymph nodes; and to determine how much SLN dissections prolonged operative time. STUDY
DESIGN: We evaluated the records of 263 consecutive patients with intermediate and high-risk melanomas (1.0 mm or thicker, or Clark Level IV or greater), who were treated by a single surgeon at the Yale Melanoma Unit between October 1, 1997, and September 30, 2001, and followed for more than 18 months.
RESULTS: A total of 655 SLN were identified and removed from these 263 consecutive patients. Radioactive colloid was found to be more reliable (100%) in identifying the SLN than lymphazurin blue dye (51%) in the nodes of the patients. Twenty-eight patients (11%) had positive sentinel lymph nodes, and 2 patients (7%) had false-negative frozen sections. Three patients (11%) had false-negative frozen sections; tumor was found subsequently on permanent sections only after special immunohistochemical stains were used. The location or removal of SLN did not prolong the operative procedure unreasonably, requiring an average of 7 to 20 minutes for removal of SLN, and 33 minutes for frozen section reports, during which time the primary tumor resection and wound coverage were performed.
CONCLUSIONS: SLN were found in all 263 patients. All SLN were identified reliably with radioactive colloid. Because blue dye was found in only half of the radioactive nodes, it is not appropriate to use this as the only marker for locating the SLN. This large series of patients attests to the reliability of frozen sections in identifying SLN harboring metastases, with 82% of the patients with nodal metastases identified in this fashion.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15194074     DOI: 10.1016/j.jamcollsurg.2004.01.034

Source DB:  PubMed          Journal:  J Am Coll Surg        ISSN: 1072-7515            Impact factor:   6.113


  6 in total

1.  Melanoma prognostic model using tissue microarrays and genetic algorithms.

Authors:  Bonnie E Gould Rothberg; Aaron J Berger; Annette M Molinaro; Antonio Subtil; Michael O Krauthammer; Robert L Camp; William R Bradley; Stephan Ariyan; Harriet M Kluger; David L Rimm
Journal:  J Clin Oncol       Date:  2009-11-02       Impact factor: 44.544

2.  Localization of the Sentinel Lymph Node in Melanoma Without Blue Dye.

Authors:  Yinin Hu; Patrick D Melmer; Craig L Slingluff
Journal:  Ann Surg       Date:  2016-03       Impact factor: 12.969

Review 3.  A comprehensive overview of radioguided surgery using gamma detection probe technology.

Authors:  Stephen P Povoski; Ryan L Neff; Cathy M Mojzisik; David M O'Malley; George H Hinkle; Nathan C Hall; Douglas A Murrey; Michael V Knopp; Edward W Martin
Journal:  World J Surg Oncol       Date:  2009-01-27       Impact factor: 2.754

4.  Utility of frozen-section analysis of sentinel lymph node biopsy specimens for melanoma in surgical decision making.

Authors:  Weesam Alkhatib; Casey Hertzenberg; William Jewell; Mazin F Al-Kasspooles; Ivan Damjanov; Mark S Cohen
Journal:  Am J Surg       Date:  2008-12       Impact factor: 2.565

5.  Methods of Sentinel Lymph Node Identification in Auricular Melanoma.

Authors:  Seth Noorbakhsh; Marianna Papageorge; Renee M Maina; Raymond Baumann; Craig Moores; Sarah A Weiss; Darko Pucar; Stephan Ariyan; Kelly Olino; James Clune
Journal:  Plast Reconstr Surg Glob Open       Date:  2021-12-20

6.  The efficacy of 99mTc-rituximab as a tracer for sentinel lymph node biopsy in cutaneous melanoma patients.

Authors:  Jiayong Liu; Zhichao Tan; Ruifeng Xue; Zhengfu Fan; Chujie Bai; Shu Li; Tian Gao; Lu Zhang; Zhiwei Fang; Lu Si
Journal:  Ann Transl Med       Date:  2022-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.